Recombinant multi-species RDH5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RDH5 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes an enzyme belonging to the short-chain dehydrogenases/reductases (SDR) family. This retinol dehydrogenase functions to catalyze the final step in the biosynthesis of 11-cis retinaldehyde, which is the universal chromophore of visual pigments. Mutations in this gene cause autosomal recessive fundus albipunctatus, a rare form of night blindness that is characterized by a delay in the regeneration of cone and rod photopigments. Alternative splicing results in multiple transcript variants. Read-through transcription also exists between this gene and the neighboring upstream BLOC1S1 (biogenesis of lysosomal organelles complex-1, subunit 1) gene. [provided by RefSeq, Dec 2010]
The Alternative Names of target: 11-cis RoDH),11-cis retinol dehydrogenase (11-cis RDH,9-cis,9-cis retinol dehydrogenase (9cRDH),9cRDH,HSD17B9,P32,RDH1,RDH4,RDH5,Rdh1,Rdh5,Retinol dehydrogenase 5,SDR9C5,Short chain dehydrogenase/reductase family 9C member 5,cRDH

Target products collectionGo to RDH5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE1504-Ag-1/ GM-Tg-hg-SE1504-Ag-2 Human RDH5 protein Human
GM-Tg-rg-SE1504-Ag-1/ GM-Tg-rg-SE1504-Ag-2 Rat RDH5 protein Rat
GM-Tg-mg-SE1504-Ag-1/ GM-Tg-mg-SE1504-Ag-2 Mouse RDH5 protein Mouse
GM-Tg-cynog-SE1504-Ag-1/ GM-Tg-cynog-SE1504-Ag-2 Cynomolgus/Rhesus macaque RDH5 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE1504-Ag-1/ GM-Tg-felg-SE1504-Ag-2 Feline RDH5 protein Feline
GM-Tg-cang-SE1504-Ag-1/ GM-Tg-cang-SE1504-Ag-2 Canine RDH5 protein Canine
GM-Tg-bovg-SE1504-Ag-1/ GM-Tg-bovg-SE1504-Ag-2 Bovine RDH5 protein Bovine
GM-Tg-equg-SE1504-Ag-1/ GM-Tg-equg-SE1504-Ag-2 Equine RDH5 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE1504-Ag-1/ GM-Tg-hg-SE1504-Ag-2; GM-Tg-rg-SE1504-Ag-1/ GM-Tg-rg-SE1504-Ag-2;
GM-Tg-mg-SE1504-Ag-1/ GM-Tg-mg-SE1504-Ag-2; GM-Tg-cynog-SE1504-Ag-1/ GM-Tg-cynog-SE1504-Ag-2;
GM-Tg-felg-SE1504-Ag-1/ GM-Tg-felg-SE1504-Ag-2; GM-Tg-cang-SE1504-Ag-1/ GM-Tg-cang-SE1504-Ag-2;
GM-Tg-bovg-SE1504-Ag-1/ GM-Tg-bovg-SE1504-Ag-2; GM-Tg-equg-SE1504-Ag-1/ GM-Tg-equg-SE1504-Ag-2
Products Name RDH5 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name RDH5
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RDH5 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.